Agios Pharmaceuticals, Inc. (AGIO) |
| 30.23 0.25 (0.83%) 02-27 16:00 |
| Open: | 29.33 |
| High: | 30.515 |
| Low: | 29.17 |
| Volume: | 634,611 |
| Market Cap: | 1,771(M) |
| PE Ratio: | -4.25 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 36.21 |
| Resistance 1: | 31.00 |
| Pivot price: | 28.57 |
| Support 1: | 27.94 |
| Support 2: | 26.04 |
| 52w High: | 46 |
| 52w Low: | 22.24 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Financials
| EPS | -7.120 |
| Book Value | 20.410 |
| PEG Ratio | 0.00 |
| Gross Profit | -4.981 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -608.90 |
| Return on Assets (ttm) | -19.9 |
| Return on Equity (ttm) | -30.2 |
Company news
Fri, 27 Feb 2026
Erste Asset Management GmbH Purchases 438,411 Shares of Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Thu, 26 Feb 2026
Agios Pharmaceuticals Q3 Loss Of US$103.4m Reinforces Bearish Profitability Narratives - Sahm
Thu, 26 Feb 2026
Agios Pharmaceuticals (NASDAQ:AGIO) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell? - MarketBeat
Tue, 24 Feb 2026
Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A 28.73% Upside Potential Amidst Strong Revenue Growth - DirectorsTalk Interviews
Thu, 19 Feb 2026
BOOTHBAY FUND MANAGEMENT, LLC's Agios Pharmaceuticals Inc(AGIO) Holding History - GuruFocus
Fri, 13 Feb 2026
Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss - Finviz
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
